FIELD: medicine, pharmaceutics.
SUBSTANCE: group of inventions relates to the field of pharmaceutics and medicine and deals with a therapeutic medication against spinal disc herniation, which represents chondroitinase ABC as an active ingredient and is introduced in such a way that the ingredient can be introduced into the person's intervertebral disc in an amount of 1-3 units per the intervertebral disc. The composition of a single dose is intended for the introduction of chondroitinase ABC into the person's intervertebral disc in an amount of 1-3 units per the intervertebral disc.
EFFECT: group of inventions makes it possible to achieve the long-lasting effect of pain relief with only a single dose introduction and can demonstrate high therapeutic effect and high safety in clinical application.
14 cl, 3 dwg, 2 tbl, 1 ex
